Uhura Bionics Launches Wearable Voice Devices for Laryngectomees

Uhura Bionics, founded by Konrad Zieliński, introduces wearable devices to aid laryngectomees in speaking with emotion, aiming for medical device classification for insurance coverage.

Uhura Bionics, a startup founded by Konrad Zieliński, has developed wearable devices designed to help individuals who have lost their voices due to laryngectomy. Zieliński, who lost his own voice to cancer, launched the company in 2023 to provide a noninvasive alternative to traditional voice prostheses and handheld speaking devices.

The company offers two models: a basic version and a high-end model named Whitney, after singer Whitney Houston. These devices allow users to express emotions vocally, including laughing, shouting, and singing. Zieliński envisions these devices being used as commonly as glasses are for vision correction.

Currently, Uhura Bionics sells its products as wellness devices, requiring users to pay out of pocket. The basic model is priced at $500, while the Whitney model costs $1,500. The startup is working towards getting these devices classified as Class I medical devices in Europe and the U.S., which would enable partial reimbursement through health insurance.

Zieliński estimates the market for devices serving laryngectomees at approximately $2 billion, with potential for growth if the company expands to address other speech disorders. Uhura Bionics faces competition from companies like Atos Medical and Laronix but aims to differentiate itself with its focus on emotional expression.

Uhura Bionics has been selected as part of TechCrunch Disrupt 2026's Startup Battlefield 200, a group of early-stage companies showcasing their innovations. Zieliński plans to demonstrate the capabilities of the Whitney device at the event, including a live singing performance, to highlight its potential impact on users' lives.